<DOC>
	<DOCNO>NCT01945944</DOCNO>
	<brief_summary>Children need ventilator often thick secretions/mucus lung . These secretion obstruct breathe tube windpipe , worsen lung function prolong need ventilator . Hypertonic saline medicine use thin secretion patient cystic fibrosis ( condition ) . We hypothesize child ventilator inhale medication shorten amount time need ventilator .</brief_summary>
	<brief_title>Nebulized Hypertonic Saline Mechanically Ventilated Children</brief_title>
	<detailed_description>Recent pediatric data show less 80 % child mechanically ventilate â‰¥ 96 hour survive PICU discharge , 100 % child mechanically ventilate &lt; 96 hour survive PICU discharge . Interventions decrease duration mechanical ventilation may improve outcome limit ventilator-induced lung injury , sedative medication usage ventilator-associated pneumonia . Obstructive airway secretion may prolong mechanical ventilation cause atelectasis endotracheal tube obstruction , resultant cardio-respiratory instability . Nebulized hypertonic saline ( HTS ) use decrease mucus viscosity increase mucociliary clearance patient diseases cystic fibrosis bronchiolitis , use enhance airway clearance mechanically ventilated child . Administering nebulized HTS mechanically ventilate child may facilitate airway clearance shorten mechanical ventilation . In randomized study child &lt; 2 year old following cardiac surgery , patient give dornase , another mucolytic agent , significantly decrease duration mechanical ventilation versus give saline placebo ( 52 hr vs. 82 hr ) . HTS may even effective , mechanically ventilate newborns persistent atelectasis improvement radiographic finding oxygen saturation randomize receive hypertonic saline compare randomized receive dornase . This may dornase may effective patient leukocytes bacterial present tracheal aspirate , HTS may effective ventilated patient . Further study impact prophylactic mucolytic therapy duration mechanical ventilation child warrant .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<criteria>invasive mechanical ventilation &lt; 12 hr duration prior enrollment expect duration mechanical ventilation &gt; 48hrs enrollment age &lt; 18yo inclusion another clinical study cystic fibrosis status asthmaticus pulmonary hemorrhage/contusion home O2 use home noninvasive positive pressure ( CPAP/BiPAP ) ventilation use preexist tracheostomy prescription mucolytic medication primary clinical team allergy inhale saline/hypertonic saline albuterol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>pediatric</keyword>
	<keyword>mucolytic</keyword>
	<keyword>respiratory failure</keyword>
	<keyword>atelectasis</keyword>
	<keyword>hypertonic saline</keyword>
</DOC>